Valuation: Optiscan Imaging Limited

Market Cap 16Cr 11Cr 10Cr 9.38Cr 8.5Cr 16Cr 1.08TCr 111.86Cr 45Cr 568.72Cr 43Cr 42Cr 1.79TCr P/E 2025
-14.5x
P/E 2026 -17.1x
Enterprise Value 15Cr 10Cr 9.38Cr 8.63Cr 7.82Cr 15Cr 994.26Cr 102.87Cr 41Cr 523.01Cr 39Cr 38Cr 1.65TCr EV / Sales 2025
23.8x
EV / Sales 2026 31.1x
Free-Float
36.64%
Yield 2025 *
-
Yield 2026 -
1 day+3.33%
1 week-3.12%
Current month+14.81%
1 month+14.81%
3 months+3.33%
6 months+40.91%
Current year+55.00%
1 week 0.14
Extreme 0.14
0.16
1 month 0.14
Extreme 0.14
0.2
Current year 0.08
Extreme 0.08
0.2
1 year 0.08
Extreme 0.08
0.2
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.26
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 13/12/2021
Director of Finance/CFO - 01/04/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 10/02/2021
Chairman - 19/04/2021
Director/Board Member - 06/05/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Exercice

Chief Executive Officer

-5,95,981 0.0571%
14/09/26 Expiration

Chief Executive Officer

-5,95,981 0.0571%
14/09/26 Exercice

Chief Executive Officer

5,95,981 0.0571%
Change 5-day change 1-year change 3-year change Capi.($)
+3.33%-3.12%+24.00%+82.35% 11Cr
-1.72%+3.44%+25.31%+60.56% 26TCr
-2.00%+0.75%+7.99%+25.46% 16TCr
-3.73%-4.48%-18.49%+67.13% 15TCr
-1.66%-8.12%-58.26%-16.12% 6.08TCr
-2.57%+3.30%+10.22%+47.55% 5.3TCr
0.00%+2.46%-11.97%-6.29% 5.33TCr
-3.47%+1.04%+21.98%+72.85% 4.93TCr
+0.84%-3.12%+9.80%+64.47% 5.07TCr
-3.61%+1.99%+34.94%+95.49% 4.55TCr
Average -1.46%-0.59%+4.55%+49.34% 8.84TCr
Weighted average by Cap. -2.10%+0.15%+5.19%+47.80%

Financials

2025 2026
Net sales 37.24L 26.2L 23.47L 21.58L 19.56L 36.56L 25Cr 2.57Cr 1.03Cr 13Cr 98.33L 96.24L 41Cr 36.13L 25.42L 22.77L 20.94L 18.98L 35.47L 24Cr 2.5Cr 1Cr 13Cr 95.4L 93.38L 40Cr
Net income -63.12L -44.41L -39.77L -36.58L -33.15L -61.96L -42Cr -4.36Cr -1.75Cr -22Cr -1.67Cr -1.63Cr -70Cr -69.86L -49.15L -44.02L -40.49L -36.69L -68.58L -47Cr -4.83Cr -1.94Cr -25Cr -1.84Cr -1.81Cr -77Cr
Net Debt -30.71L -21.6L -19.35L -17.8L -16.13L -30.14L -21Cr -2.12Cr -85.2L -11Cr -81.08L -79.35L -34Cr -1.3Cr -91.51L -81.96L -75.39L -68.31L -1.28Cr -87Cr -8.99Cr -3.61Cr -46Cr -3.43Cr -3.36Cr -144.14Cr
Projected Income Statement - Annual - Optiscan Imaging Limited
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
30/26/30 A$0.1550 +3.33% 2,00,756
29/26/29 A$0.1500 +3.45% 46,395
28/26/28 A$0.1450 +3.57% 22,023
27/26/27 A$0.1400 -9.68% 57,321
26/26/26 A$0.1550 -3.13% 2,09,042